Company Overview

Jiangxi Kvvit Pharmaceutical Co., Ltd., a holding subsidiary of Qingfeng Pharmaceutical Group, is an innovation-driven pharmaceutical company with an international outlook. The company has built fully integrated capabilities spanning drug discovery, development, manufacturing, and commercialization.

Focusing on unmet clinical needs worldwide, the Company concentrates on four major therapeutic areas: anti-infection, oncology, central nervous system, and gastroenterology. Adopting an innovative R&D strategy of differentiated competition, it is committed to providing patients with high-quality healthcare products and services featuring better efficacy and wider accessibility.

  • 1500 +
    Employee headcount
  • 4
    Collaborative & efficient R&D centers
  • 2
    Modern pharmaceutical commercial production bases
  • 60
    Pipeline candidates under research
  • 60 +
    MA approvals obtained
  • 21
    Products selected in national volume-based procurement

Business Philosophy

Futurism
Futurism
Long-termism
Long-termism
Valueism
Valueism
Qualifications & Honors
National High-tech Enterprise
2024
US-GMP
2024
cGMP
2001

Sustainable Development (ESG)

Sustainable Development (ESG)

We take proactive responsibility for employees, patients and the environment.

Kvvit Pharmaceutical attaches great importance to corporate social value and actively assumes responsibilities toward employees, patients and the environment. Throughout production operations, the Company prioritizes human value and highlights its contributions to environmental protection, consumer protection and social development.

Contact Us

Jiangxi Kvvit Pharmaceutical Co., Ltd.

Tel: 0797-5560800 
Fax: 0797-5560620 
Email for Inquiries: krgw@kvvit.com 
Address: No.188 Qingfeng Avenue, Zhanggong District, Ganzhou City, Jiangxi Province, China.

Business Development

Leave a Message
Full Name*
Contact Information*
Company Name
Email*
Location*
Please describe your application scenario, technical/material requirements and personalized demands in detail